Two EPAD early career researchers successfully defended their PhD thesis in March 2020. On 13 March 2020, Lisa Vermunt successfully defended her PhD thesis entitled “Secondary prevention for Alzheimer disease – timing, selection and endpoint of clinical trials” at the VU University in Amsterdam (Netherlands). This work was conducted in the context of the EPAD project and was the first EPAD PhD to be completed including EPAD content. In this thesis, Lisa investigated the duration of the Alzheimer’s disease stages. The findings in this thesis improve the insight in the disease course of Alzheimer’s disease, including the pre-dementia period. On 16 March 2020, Lucy Stirland defended her thesis at the University of Edinburgh (UK). Her thesis is titled “Epidemiology of multimorbidity and polypharmacy in ageing: a complementary analysis of mental and brain health in three datasets”. Her thesis focused on the mental and brain health of people with multiple physical conditions. Most people with a long-term condition have more than one illness, so it's important to study combinations of diseases. Lucy looked at data from three sources: EPAD, the PREVENT Dementia study and she also routinely collected data from the Scottish National Health Service.
The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115736, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
http://ep-ad.org/2020/04/20/two-epad-fellows-successfully-defended-their-phd-thesis/
